Verastem, Inc.

VSTM ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $136.4M $165.6M $205.0M $137.7M $164.3M $117.6M $88.8M $113.2M
Accounts Receivable — — — — — — — —
Inventory $2.4M $2.3M $1.8M $1.8M $1.2M — — —
Total Current Assets $176.2M $202.9M $223.4M $154.1M $174.3M $124.7M $95.0M $120.7M
Property, Plant & Equipment — — — $20.0K $21.0K $22.0K $32.0K $39.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) $15.9M $16.1M $16.4M $16.7M $15.6M — — —
Total Assets $206.5M $227.8M $246.4M $176.9M $196.3M $131.7M $101.5M $126.4M
Liabilities
Accounts Payable $18.0M $9.6M $12.4M $9.9M $8.0M $7.2M $4.0M $4.4M
Total Current Liabilities $78.1M $66.8M $72.3M $59.7M $50.4M $35.6M $31.0M $37.4M
Long-Term Debt — — — — — — $40.7M $40.5M
Total Liabilities $156.5M $146.0M $189.2M $192.4M $160.2M $164.1M $130.4M $94.2M
Stockholders' Equity
Retained Earnings $-1.24B $-1.20B $-1.16B $-1.13B $-1.03B $-1.01B $-955.5M $-891.0M
Total Stockholders' Equity $50.0M $81.8M $57.2M $-15.5M $36.1M $-32.4M $-28.9M $11.1M
← Newer Page 1 of 8 Older →